Last 7 days
-3.6%
Last 30 days
-15.5%
Last 90 days
-15.4%
Trailing 12 Months
-3.0%
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
SYK | 110.8B | 19.0B | -8.78% | 16.43% | 46.98 | 6.01 | 8.73% | 30.37% |
ISRG | 107.5B | 6.4B | 4.05% | 37.44% | 81.96 | 16.72 | 8.89% | -20.19% |
BSX | 74.1B | 13.0B | -0.08% | 27.20% | 106.12 | 5.84 | 7.26% | -32.95% |
BDX | 71.3B | 18.8B | -6.73% | -3.13% | 44.09 | 3.79 | -1.96% | -15.83% |
EW | 49.7B | 5.5B | -6.18% | -16.80% | 33.38 | 9.03 | 2.68% | -3.23% |
MID-CAP | ||||||||
SWAV | 7.2T | 557.2M | -1.64% | 66.40% | 82.2K | 16.8K | 86.42% | 730.06% |
PEN | 11.7B | 884.6M | 7.85% | 115.97% | 1.8K | 13.2 | 13.08% | 200.12% |
GMED | 5.9B | 1.1B | -8.20% | -19.98% | 34.14 | 5.75 | 11.20% | 53.04% |
IRTC | 3.6B | 430.0M | -11.89% | -12.63% | -34.73 | 8.45 | 26.13% | 15.73% |
TNDM | 1.7B | 794.7M | -29.15% | -60.56% | -8.43 | 2.16 | 7.73% | -3556.34% |
SMALL-CAP | ||||||||
ATEC | 1.6B | 389.0M | -3.76% | 82.19% | -10.63 | 4.18 | 44.08% | 6.96% |
SILK | 1.2B | 150.7M | -30.80% | 0.49% | -21.65 | 7.87 | 40.31% | 1.80% |
AVNS | 1.1B | 814.3M | -20.14% | -16.22% | 24.47 | 1.34 | 6.96% | 121.89% |
CSII | 839.3M | 239.8M | 0.70% | 0.15% | -22.16 | 3.5 | -4.74% | -31.15% |
Income Statement (Last 12 Months) | ||||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 |
Revenue | 8.1% | 295,932,000 | 273,702,000 | 240,919,000 | 217,448,000 | 194,337,000 |
Gross Profit | 9.7% | 216,923,000 | 197,665,000 | 170,089,000 | 150,023,000 | 128,561,000 |
Operating Expenses | 3.8% | 272,702,000 | 262,611,000 | 249,106,000 | 229,167,000 | 202,286,000 |
S&GA Expenses | 6.1% | 165,610,000 | 156,019,000 | 143,533,000 | 131,894,000 | 117,924,000 |
R&D Expenses | -9.2% | 31,230,000 | 34,410,000 | 36,489,000 | 37,201,000 | 39,164,000 |
EBITDA | 26.3% | -50,594,000 | -68,627,000 | -68,807,000 | -66,975,000 | - |
EBITDA Margin | 35.1% | -0.18 | -0.28 | -0.32 | -0.34 | - |
Earnings Before Taxes | 22.0% | -48,592,000 | -62,316,000 | -80,112,000 | -80,062,000 | -80,006,000 |
EBT Margin | 31.5% | -0.23 | -0.33 | -0.37 | -0.41 | - |
Interest Expenses | -100.0% | 0.00 | 1,000 | 1,000 | 2,000 | 2,009,000 |
Net Income | 22.5% | -46,278,000 | -59,698,000 | -75,530,000 | -76,528,000 | -80,233,000 |
Net Income Margin | 30.4% | -0.22 | -0.31 | -0.35 | -0.41 | - |
Free Cahsflow | 106.1% | 968,000 | -15,910,000 | -22,472,000 | -33,319,000 | - |
Balance Sheet | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 |
Assets | 1.0% | 666 | 659 | 632 | 514 | 526 |
Current Assets | 1.0% | 470 | 465 | 449 | 313 | 307 |
Cash Equivalents | 0.5% | 240 | 239 | 241 | 203 | 213 |
Inventory | 18.5% | 66.00 | 56.00 | 58.00 | 58.00 | 62.00 |
Net PPE | 3.2% | 7.00 | 7.00 | 7.00 | 7.00 | 7.00 |
Goodwill | 2.3% | 97.00 | 94.00 | 87.00 | 95.00 | 103 |
Liabilities | -0.1% | 89.00 | 89.00 | 83.00 | 76.00 | 62.00 |
Current Liabilities | 1.4% | 66.00 | 65.00 | 61.00 | 30.00 | 26.00 |
Shareholder's Equity | 1.1% | 577 | 570 | 550 | 438 | 463 |
Retained Earnings | -2.5% | -383 | -374 | -374 | -358 | -337 |
Additional Paid-In Capital | 1.3% | 982 | 970 | 961 | 821 | 812 |
Accumulated Depreciation | 8.0% | 7.00 | 7.00 | 6.00 | - | - |
Shares Outstanding | 1.1% | 50.00 | 50.00 | 49.00 | 47.00 | 47.00 |
Cashflow (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 |
Cashflow From Operations | 262.8% | 12.00 | 3.00 | -12.94 | -19.78 | -30.89 |
Share Based Compensation | 11.2% | 36.00 | 32.00 | 30.00 | 29.00 | 27.00 |
Cashflow From Investing | 0.8% | -119 | -120 | -111 | -12.69 | -2.43 |
Cashflow From Financing | 0.4% | 134 | 134 | 134 | 4.00 | 116 |
75.1%
56.4%
44.0%
Y-axis is the maximum loss one would have experienced if Axonics Modulation Tech was unfortunately bought at previous high price.
8.5%
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-05-23 | ROYCE & ASSOCIATES LP | reduced | -31.76 | -2,150,570 | 3,164,480 | 0.03% |
2023-05-22 | AMERIPRISE FINANCIAL INC | reduced | -37.00 | -14,875,900 | 18,160,100 | 0.01% |
2023-05-22 | PUTNAM INVESTMENTS LLC | added | 0.33 | -1,009,090 | 7,090,670 | 0.01% |
2023-05-18 | JPMORGAN CHASE & CO | added | 9.68 | -1,029,940 | 22,928,100 | -% |
2023-05-18 | NEW YORK STATE COMMON RETIREMENT FUND | reduced | -30.19 | -2,888,000 | 4,500,000 | 0.01% |
2023-05-17 | Thrivent Financial for Lutherans | added | 2.19 | -1,501,000 | 12,340,000 | 0.03% |
2023-05-17 | Advisory Services Network, LLC | unchanged | - | -2,017 | 13,804 | -% |
2023-05-17 | VIRGINIA RETIREMENT SYSTEMS ET AL | added | 18.87 | 41,214 | 787,878 | 0.01% |
2023-05-16 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | added | 125 | 587,551 | 1,197,160 | -% |
2023-05-16 | Rockefeller Capital Management L.P. | added | 41.04 | 39,000 | 208,000 | -% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Mar 10, 2023 | vanguard group inc | 10.28% | 5,092,888 | SC 13G/A | |
Feb 09, 2023 | fmr llc | - | 0 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 9.82% | 4,863,283 | SC 13G/A | |
Jan 31, 2023 | blackrock inc. | 7.3% | 3,630,843 | SC 13G/A | |
Jun 06, 2022 | cooperatieve gilde healthcare iv u.a. | 0% | 0 | SC 13G/A | |
Feb 14, 2022 | credit suisse ag/ | 4.90% | 2,273,198 | SC 13G/A | |
Feb 09, 2022 | vanguard group inc | 6.27% | 2,902,696 | SC 13G | |
Feb 09, 2022 | fmr llc | - | 0 | SC 13G/A | |
Feb 03, 2022 | blackrock inc. | 7.6% | 3,525,549 | SC 13G/A | |
Apr 08, 2021 | alfred e. mann foundation for scientific research | 4.0% | 1,602,970 | SC 13G/A |
Date Filed | Form Type | Document | |
---|---|---|---|
May 18, 2023 | 424B5 | Prospectus Filed | |
May 18, 2023 | 8-K | Current Report | |
May 05, 2023 | S-3ASR | S-3ASR | |
May 02, 2023 | 10-Q | Quarterly Report | |
May 01, 2023 | 8-K | Current Report | |
May 01, 2023 | DEF 14A | DEF 14A | |
Apr 25, 2023 | 4 | Insider Trading | |
Apr 24, 2023 | 4 | Insider Trading | |
Apr 20, 2023 | 144 | Notice of Insider Sale Intent | |
Apr 06, 2023 | 8-K | Current Report |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-04-21 | Dearen Danny L. | sold | -1,204,140 | 60.2069 | -20,000 | president & cfo |
2023-04-21 | Dearen Danny L. | acquired | 187,422 | 14.19 | 13,208 | president & cfo |
2023-04-20 | Dearen Danny L. | acquired | 28,394 | 14.19 | 2,001 | president & cfo |
2023-04-20 | Dearen Danny L. | sold | -120,073 | 60.0063 | -2,001 | president & cfo |
2023-03-31 | Dearen Danny L. | sold | -829,103 | 55.2735 | -15,000 | president & cfo |
2023-03-31 | Dearen Danny L. | acquired | 240,031 | 16.0021 | 15,000 | president & cfo |
2023-02-21 | Sama Rinda | sold | -191,750 | 56.53 | -3,392 | chief operating officer |
2023-02-21 | Sama Rinda | sold | -1,121,410 | 56.2705 | -19,929 | chief operating officer |
2023-02-01 | Ford Alfred J Jr | sold | -225,750 | 60.9311 | -3,705 | chief commercial officer |
2023-02-01 | Dearen Danny L. | sold | -197,782 | 60.9311 | -3,246 | president & cfo |
Condensed Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2023 | Mar. 31, 2022 | |
Statement of Comprehensive Income [Abstract] | ||
Net revenue | $ 70,650 | $ 48,420 |
Cost of goods sold | 18,150 | 15,178 |
Gross profit | 52,500 | 33,242 |
Operating expenses | ||
Research and development | 8,056 | 11,236 |
General and administrative | 12,168 | 10,013 |
Sales and marketing | 42,654 | 33,063 |
Amortization of intangible assets | 2,222 | 2,463 |
Acquisition-related costs | 1,766 | 0 |
Total operating expenses | 66,866 | 56,775 |
Loss from operations | (14,366) | (23,533) |
Other income (expense) | ||
Interest and other income | 3,628 | 43 |
Interest and other expense | 683 | (289) |
Other income (expense), net | 4,311 | (246) |
Loss before income tax benefit | (10,055) | (23,779) |
Income tax benefit | (807) | (1,111) |
Net loss | (9,248) | (22,668) |
Foreign currency translation adjustment | 3,071 | (4,920) |
Comprehensive loss | $ (6,177) | $ (27,588) |
Net loss per share, basic (in USD per share) | $ (0.19) | $ (0.50) |
Net loss per share, diluted (in USD per share) | $ (0.19) | $ (0.50) |
Weighted-average shares used to compute basic net loss per share (in shares) | 48,579,084 | 45,139,038 |
Weighted-average shares used to compute diluted net loss per share (in shares) | 48,579,084 | 45,139,038 |
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Mar. 31, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets | ||
Cash and cash equivalents | $ 240,105 | $ 238,846 |
Short-term investments | 116,957 | 118,365 |
Accounts receivable, net of allowance for credit losses of $322 and $321 at March 31, 2023 and December 31, 2022, respectively | 40,200 | 44,817 |
Inventory, net | 66,067 | 55,765 |
Prepaid expenses and other current assets | 6,342 | 7,282 |
Total current assets | 469,671 | 465,075 |
Property and equipment, net | 7,017 | 6,798 |
Intangible assets, net | 85,888 | 86,253 |
Other assets | 6,534 | 6,813 |
Goodwill | 96,581 | 94,414 |
Total assets | 665,691 | 659,353 |
Current liabilities | ||
Accounts payable | 14,737 | 9,070 |
Accrued liabilities | 6,640 | 6,520 |
Accrued compensation and benefits | 8,836 | 15,495 |
Operating lease liability, current portion | 1,557 | 1,562 |
Other current liabilities | 34,400 | 32,600 |
Total current liabilities | 66,170 | 65,247 |
Operating lease liability, net of current portion | 7,178 | 7,555 |
Deferred tax liabilities, net | 15,737 | 16,412 |
Total liabilities | 89,085 | 89,214 |
Commitments and contingencies (Note 3) | ||
Stockholders’ equity | ||
Preferred stock, par value $0.0001 per share; 10,000,000 shares authorized, no shares issued and outstanding at March 31, 2023 and December 31, 2022 | 0 | 0 |
Common stock, par value $0.0001, 75,000,000 shares authorized at March 31, 2023 and December 31, 2022; 50,110,667 and 49,546,727 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively | 5 | 5 |
Additional paid-in capital | 982,189 | 969,545 |
Accumulated deficit | (383,512) | (374,264) |
Accumulated other comprehensive loss | (22,076) | (25,147) |
Total stockholders’ equity | 576,606 | 570,139 |
Total liabilities and stockholders’ equity | $ 665,691 | $ 659,353 |